연구성과로 돌아가기
JCR 2024 저널 목록 (1286 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WATER SCIENCE AND TECHNOLOGY | IWA PUBLISHING | 0273-1223 | 1996-9732 | SCIE | ENGINEERING, ENVIRONMENTAL | 22,066 | 2.6 | Q3 | 65.7 | 34.3 | 55/83 | 2.7 | Q3 | 2.5 | 0.7 | 0.45 | 50/83 | Q3 | 40.36 | 0.007 | 1.571 | 0.373 | Q4 | 394 | 93.4% | 10.3 | 6.0 | 368 | 95.3% | 2025-08-05 16:33:29 | 바로가기 |
| ACTA NEUROCHIRURGICA | SPRINGER WIEN | 0001-6268 | 0942-0940 | SCIE | CLINICAL NEUROLOGY | 11,686 | 1.9 | Q3 | 65.8 | 34.2 | 188/285 | 2.2 | Q3 | 1.7 | 0.4 | 0.73 | 137/285 | Q2 | 52.11 | 0.009 | 2.088 | 0.651 | Q3 | 471 | 90.2% | 8.9 | 8.1 | 425 | 35.2% | 2025-08-05 16:02:42 | 바로가기 |
| BIOPHARMACEUTICS & DRUG DISPOSITION | WILEY | 0142-2782 | 1099-081X | SCIE | PHARMACOLOGY & PHARMACY | 1,493 | 2.0 | Q3 | 65.8 | 34.2 | 232/352 | 1.8 | Q3 | 2.0 | 0.6 | 0.52 | 227/353 | Q3 | 35.84 | 0.000 | 0.110 | 0.394 | Q3 | 16 | 93.8% | 13.0 | 13.7 | 15 | 17.3% | 2025-08-05 16:04:35 | 바로가기 |
| BRAIN BEHAVIOR AND EVOLUTION | KARGER | 0006-8977 | 1421-9743 | SCIE | BEHAVIORAL SCIENCES | 1,963 | 1.8 | Q3 | 65.8 | 34.2 | 38/57 | 1.5 | Q4 | 1.6 | 0.2 | 0.66 | 38/57 | Q3 | 34.21 | 0.001 | 0.131 | 0.665 | Q3 | 25 | 68.0% | 19.0 | 15.5 | 17 | 29.9% | 2025-08-05 16:02:31 | 바로가기 |
| CHILD NEUROPSYCHOLOGY | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | 0929-7049 | 1744-4136 | SCIE | CLINICAL NEUROLOGY | 2,909 | 1.9 | Q3 | 65.8 | 34.2 | 188/285 | 2.3 | Q3 | 1.7 | 0.4 | 0.57 | 192/285 | Q3 | 32.81 | 0.002 | 0.416 | 0.690 | Q3 | 60 | 95.0% | 10.6 | 10.6 | 57 | 20.3% | 2025-08-05 16:02:42 | 바로가기 |
| Current Alzheimer Research | BENTHAM SCIENCE PUBL LTD | 1567-2050 | 1875-5828 | SCIE | CLINICAL NEUROLOGY | 4,748 | 1.9 | Q3 | 65.8 | 34.2 | 188/285 | 2.6 | Q3 | 1.8 | 0.5 | 0.45 | 222/285 | Q4 | 22.28 | 0.002 | 0.513 | 0.624 | Q3 | 60 | 70.0% | 8.6 | 6.8 | 42 | 5.9% | 2025-08-05 16:02:42 | 바로가기 |
| Cutaneous and Ocular Toxicology | TAYLOR & FRANCIS LTD | 1556-9527 | 1556-9535 | SCIE | OPHTHALMOLOGY | 1,009 | 1.3 | Q3 | 65.8 | 34.2 | 65/98 | 1.5 | Q3 | 1.2 | 0.3 | 0.47 | 69/98 | Q3 | 30.10 | 0.001 | 0.141 | 0.306 | Q4 | 49 | 93.9% | 7.4 | 8.3 | 46 | 5.0% | 2025-08-05 16:04:27 | 바로가기 |
| DEMENTIA AND GERIATRIC COGNITIVE DISORDERS | KARGER | 1420-8008 | 1421-9824 | SCIE | CLINICAL NEUROLOGY | 4,624 | 1.9 | Q3 | 65.8 | 34.2 | 188/285 | 2.9 | Q2 | 1.8 | 0.4 | 0.55 | 196/285 | Q3 | 31.40 | 0.002 | 0.407 | 0.819 | Q3 | 52 | 96.2% | 13.4 | 7.6 | 50 | 8.4% | 2025-08-05 16:02:42 | 바로가기 |
| Endocrine Metabolic & Immune Disorders-Drug Targets | BENTHAM SCIENCE PUBL LTD | 1871-5303 | 2212-3873 | SCIE | PHARMACOLOGY & PHARMACY | 2,539 | 2.0 | Q3 | 65.8 | 34.2 | 232/352 | 2.0 | Q3 | 1.9 | 0.6 | 0.45 | 256/353 | Q3 | 27.62 | 0.003 | 0.565 | 0.382 | Q3 | 233 | 63.5% | 4.1 | 6.8 | 148 | 3.9% | 2025-08-05 16:04:34 | 바로가기 |
| Forestist | AVES | 2602-4039 | 2602-4039 | ESCI | FORESTRY | 119 | 0.8 | Q3 | 65.8 | 34.2 | 61/92 | 0.7 | Q4 | 0.7 | 0.3 | 0.31 | 62/92 | Q3 | 33.15 | 0.000 | 0.026 | 0.116 | Q4 | 43 | 97.7% | 2.8 | 9.4 | 42 | 98.2% | 2025-08-05 16:03:18 | 바로가기 |
| FORESTRY CHRONICLE | CANADIAN INST FORESTRY | 0015-7546 | 1499-9315 | SCIE | FORESTRY | 1,295 | 0.8 | Q3 | 65.8 | 34.2 | 61/92 | 1.0 | Q3 | 0.7 | 0.5 | 0.24 | 71/92 | Q4 | 23.37 | 0.000 | 0.032 | 0.193 | Q3 | 24 | 100.0% | 18.8 | 8.5 | 24 | 35.7% | 2025-08-05 16:03:18 | 바로가기 |
| JOURNAL OF AAPOS | MOSBY-ELSEVIER | 1091-8531 | 1528-3933 | SCIE | OPHTHALMOLOGY | 3,237 | 1.3 | Q3 | 65.8 | 34.2 | 65/98 | 1.2 | Q4 | 1.2 | 0.2 | 0.57 | 64/98 | Q3 | 35.20 | 0.002 | 0.465 | 0.401 | Q3 | 123 | 96.8% | 11.3 | 9.6 | 119 | 7.4% | 2025-08-05 16:04:27 | 바로가기 |
| Journal of Applied Biomedicine | UNIV SOUTH BOHEMIA | 1214-021X | 1214-0287 | SCIE | PHARMACOLOGY & PHARMACY | 735 | 2.0 | Q3 | 65.8 | 34.2 | 232/352 | 1.8 | Q3 | 1.9 | 0.2 | 0.53 | 221/353 | Q3 | 37.54 | 0.000 | 0.060 | 0.294 | Q4 | 28 | 89.3% | 7.9 | 8.5 | 25 | 98.6% | 2025-08-05 16:04:35 | 바로가기 |
| Journal of Applied Mathematics | WILEY | 1110-757X | 1687-0042 | ESCI | MATHEMATICS, INTERDISCIPLINARY APPLICATIONS | 2,300 | 1.3 | Q3 | 65.8 | 34.2 | 90/136 | 1.5 | Q3 | 1.3 | 0.6 | 0.47 | 84/136 | Q3 | 38.60 | 0.001 | 0.128 | 0.274 | Q4 | 63 | 100.0% | 11.0 | 6.6 | 63 | 100.0% | 2025-08-05 16:04:02 | 바로가기 |
| JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | WILEY | 0269-4727 | 1365-2710 | SCIE | PHARMACOLOGY & PHARMACY | 4,251 | 2.0 | Q3 | 65.8 | 34.2 | 232/352 | 2.2 | Q3 | 2.0 | 0.3 | 0.44 | 261/353 | Q3 | 26.20 | 0.004 | 0.939 | 0.607 | Q3 | 47 | 87.2% | 6.7 | 6.8 | 41 | 68.8% | 2025-08-05 16:04:34 | 바로가기 |
페이지 이동: